Scientists find a drug that can extend life span

Credit: Unsplash+

A recent study from the University of Auckland has brought us one step closer to the long-standing dream of extending human life.

Researchers have discovered that a drug, currently used to treat cancer, could significantly increase the lifespan of mice. While the results are promising, the implications for human aging remain uncertain.

The study focused on a drug called alpelisib, which has been in use for treating certain types of cancer. The researchers administered this drug to healthy mice starting from middle age, which for mice is about one year old.

The mice continued this treatment throughout their lives. The results were notable: the mice that received the drug lived, on average, 10% longer than those that did not, extending their lifespan to around three years.

This increase is equivalent to several additional months of life, which is significant given the natural lifespan of mice.

But it wasn’t just about living longer. The mice treated with alpelisib also showed some signs of healthier aging. For example, they demonstrated better coordination and strength in old age compared to the untreated group.

These findings suggest that the drug may not only extend life but also improve the quality of life in older age.

However, the researchers urge caution in interpreting these results, especially when considering potential applications for humans. While the drug extended lifespan and appeared to enhance certain aspects of health, it also came with some drawbacks.

The treated mice exhibited lower bone mass, a common marker of aging that can lead to frailty and increased risk of fractures. This highlights the complexity of using such treatments to extend life; the benefits must be weighed against the possible side effects.

The scientists are clear in their message: they do not recommend people start taking alpelisib or similar drugs in an attempt to live longer.

The drug’s side effects in humans could be serious, and its long-term impact on human health is not yet understood. However, the study does open up new avenues of research into the biological mechanisms of aging.

Alpelisib works by targeting an enzyme known as PI 3-kinase, which plays a role in various cellular processes, including the regulation of cell growth and survival.

For over 20 years, researchers have been exploring drugs that can inhibit this enzyme, mainly due to its involvement in cancer. Many cancers are driven by excessive activation of the PI 3-kinase pathway, making it an attractive target for cancer therapies.

What’s exciting about this study is that it shows how these drugs might also be useful in other areas, such as aging and age-related diseases.

This research highlights the importance of long-term investment in scientific exploration. Drugs developed for one purpose, like treating cancer, may have unexpected benefits in other areas, such as extending lifespan or improving health during aging.

This dual potential underscores the need for continued research into the underlying mechanisms of aging and disease.

Looking ahead, the researchers plan to explore how shorter-term treatments with alpelisib might be used to address specific metabolic health issues. They believe that understanding the mechanisms by which this drug affects aging could lead to new strategies for improving health and longevity.

While this study offers exciting possibilities, it is just the beginning of a much larger conversation about how we can extend human life and improve the quality of our later years.

For those interested in health and longevity, this research serves as a reminder of the potential that lies in ongoing scientific inquiry.

The study, led by Dr. Chris Hedges and his team, has been published in Nature Aging. As scientists continue to unravel the complexities of aging, discoveries like this one offer hope that we may one day be able to not only live longer but live better in our later years.

If you care about health, please read studies that vitamin D can help reduce inflammation, and vitamin K could lower your heart disease risk by a third.

For more health information, please see recent studies about new way to halt excessive inflammation, and results showing foods that could cause inflammation.

Copyright © 2024 Knowridge Science Report. All rights reserved.